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Abstract
Background: Salmonella infection is a common public health problem that can become chronic and increase the risk of
inflammatory bowel diseases and cancer. AvrA is a Salmonella bacterial type III secretion effector protein. Increasing
evidence demonstrates that AvrA is a multi-functional enzyme with critical roles in inhibiting inflammation, regulating
apoptosis, and enhancing proliferation. However, the chronic effects of Salmonella and effector AvrA in vivo are still
unknown. Moreover, alive, mutated, non-invasive Salmonella is used as a vector to specifically target cancer cells. However,
studies are lacking on chronic infection with non-pathogenic or mutated Salmonella in the host.
Methods/Principal Findings: We infected mice with Salmonella Typhimurium for 27 weeks and investigated the
physiological effects as well as the role of AvrA in intestinal inflammation. We found altered body weight, intestinal
pathology, and bacterial translocation in spleen, liver, and gallbladder in chronically Salmonella-infected mice. Moreover,
AvrA suppressed intestinal inflammation and inhibited the secretion of cytokines IL-12, IFN-c, and TNF-a. AvrA expression in
Salmonella enhanced its invasion ability. Liver abscess and Salmonella translocation in the gallbladder were observed and
may be associated with AvrA expression in Salmonella.
Conclusion/Significance: We created a mouse model with persistent Salmonella infection in vivo. Our study further
emphasizes the importance of the Salmonella effector protein AvrA in intestinal inflammation, bacterial translocation, and
chronic infection in vivo.
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Introduction
Salmonellosis is one of the most common enteric infections in
the United States. In addition to the public health concern of
Salmonella outbreaks, Salmonella colonization and infection can be
chronic [1] and increase the risk of other gastrointestinal (GI)
diseases, including chronic inflammation and gallbladder cancer
[2,3]. A recent population-based cohort study demonstrates an
increased risk of inflammatory bowel diseases in individuals with
Salmonella infection [2]. Chronic Salmonella colonization in
intestine increases the risk of the intestinal fibrosis in mice
[1]. Although the pathogenesis of Salmonella-induced diarrhea and
inflammation has been extensively studied [4], how Salmonella
regulates the host responses in the long term remains
unknown.
Increasing evidence links some Salmonella species to carcinogen-
esis, whereas others appear promising in the diagnosis, prevention,
or treatment of cancers [5]. Salmonella and its derivatives prefer
solid tumors over normal tissue in animal models [6,7]. Alive,
mutated, non-invasive Salmonella has been used as a vector to
specifically target cancer cells [8]. However, there have been no
studies on chronic infection with non-pathogenic or mutated
Salmonella in the host.
Bacteria can modulate host physiology by secreting bacterial
proteins, called effectors, through a type III secretion system
[9,10,11,12]. These ’molecular syringes’ inject effectors directly
into the host cell, whereupon they manipulate host cell functions
[13,14,15,16]. AvrA is a bacterial effector protein existing in both
Salmonella and E. coli strains [17]. Increasing evidence demonstrates
that AvrA is a multi-functional protein with critical roles in
inhibiting inflammation, regulating epithelial apoptosis, and
enhancing proliferation [17,18,19,20,21,22,23]. However, the
chronic effects of Salmonella AvrA in vivo are unexplored.
We colonized the mouse intestine with Salmonella Typhimurium
for 27 weeks. To determine whether AvrA is responsible for the
chronic intestinal inflammation, we focused on bacterial strainswith
parental PhoP
c, PhoP
c AvrA mutant (AvrA
2), and PhoP
c AvrA
2
with a complemented plasmid encoding AvrA (PhoP
c AvrA
2/
AvrA
+) in vivo, as we used in previous studies [20,21,22,24,25]. We
observed the bacteria in intestine, the translocation of Salmonella in
liver, gallbladder, and spleen, and inflammatory responses of
intestinal mucosa over 27 weeks. We observed that AvrA
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expression in Salmonella enhanced its invasion ability. Liver abscess
and Salmonella translocation in the gallbladder were observed and
may be associated with AvrA expression in Salmonella. Overall, our
study emphasizes the importance of AvrA in Salmonella-induced
intestinal inflammation and chronic infection in vivo.
Results
Persistence of Salmonella infection in the streptomycin-
pretreated mouse model
S. Typhimurium infection can last over several months in vivo
[1]. However, it is uncertain whether Salmonella PhoP
c and its
derived mutations are able to colonize the intestine in vivo.W e
tested AvrA
+ and AvrA
2 bacterial colonization in mice post
infection for 27 weeks. We collected tissue samples at 1, 3, 6, 10,
and 27 weeks postinfection (Fig. 1A). First, we confirmed the
colonization of Salmonella in the intestine by fecal bacterial culture.
Salmonella existence and AvrA expression in the gut flora were also
confirmed by Salmonella culture (Fig. 1B). Immunofluorescence
analysis of intestinal tissue samples showed the invasion of
Salmonella in intestinal mucosa at 27 weeks postinfection (Fig. 1C).
PCR of AvrA further confirmed that AvrA was expressed in the
mouse intestine and feces (data not shown). These data
demonstrate that one gavage of Salmonella was sufficient to induce
persistent Salmonella colonization in the intestine for 27 weeks in
the streptomycin-pretreated mouse model.
Chronic Salmonella infection retards body weight gain in
the streptomycin-pretreated mouse model
Bacterial infection may induce weight loss in mice. We
monitored changes in body weight in the control and Salmonella-
infected mice for 27 weeks (Fig. 2A and Table 1). From week 0 to
week 27, overall weight increased for all these four groups, that is,
there are time effects among these four groups. The increasing
rates were significantly different between control and Salmonella–
infected group, PhoP
c, Phop
cAvrA
2, or Phop
cAvrA
2/Avra
+,
although there were no significant differences among all these
three Salmonella–infected groups. During the beginning 2 weeks
after Salmonella infection, the mice body weights increasing rates
from the three Salmonella–infected groups all slowed down, until
week 2 or 3, the average weight of all the three Salmonella–treated
groups were significantly lower that the control group at the .05
significance level. For PhoP
c vs. control, the difference started at
week 2, continued until week 9; for Phop
cAvrA
2, vs. control, the
difference started at week 2, lasted to week 6; as for Phop
cAvrA/
Avra
+ vs. Control, the difference started at week 3, but over the
whole treatment period until week 27. In other words, the body
weight loss in the three Salmonella–infected mice need 4 to 7 weeks,
even 24 weeks to catch up.
Various survival rates in mice infected with different
Salmonella strains
The PhoP
c strain was derived from pathogenic Salmonella
SL14028 and was used as a non-pathogenic Salmonella strain in
previous short-term intestinal inflammation studies [26]
[21,24,25]. However, we found that PhoP
c Salmonella infection
could be lethal in mice (Fig. 2B). Survival analysis showed that
most deaths occurred at 3 weeks postinfection. After the acute
infection stage, mice survived with persistent Salmonella detected in
intestine for 27 weeks. The PhoP
c Salmonella infection group had
the highest survival rate, 90%, whereas AvrA
2 had a survival rate
of 77%, and that of PhoP
c AvrA
2/AvrA
+ was 68%. These data
indicate that complementary plasmid-expressed AvrA in the
AvrA
2 strain was not able to increase the survival rate during
long-term infection.
Intestinal shortening induced by Salmonella in vivo
Cecal shortening and inflammation are the key features in the
Salmonella-colitis mouse model [27]. We found that the lengths of
ceca in groups infected with Salmonella were decreased compared
to the mice without Salmonella infection. At 3 weeks postinfection,
significant shortening of ceca was found in the AvrA
2 infection
group compared to the PhoP
c group (Fig. 3A). Inflammation and
gross pathology are focused on the cecum, with some inflamma-
tion in the contiguous colon in the streptomycin-pretreated
Salmonella colitis model [28]. We also measured the lengths of
small intestine and colon but did not find significant differences
(Fig. 3B and C).
Pathologic changes caused by chronic Salmonella
infection in streptomycin-pretreated mice
We investigated the pathologic changes caused by chronic
Salmonella infection in streptomycin-pretreated mice. H&E staining
showed severe intestinal inflammation in mice infected with
Salmonella Typhimurium AvrA
2 at 1, 3, 6, 10, and 27 weeks
postinfection compared to the wild-type mice (Fig. 4A). Next, the
level of cecal inflammation was quantified histologically. After 3
week post treatment, the mean cecum histologic score for
PhoP
cAvrA
2 group was significantly higher than that of control
group; PhoP
cAvrA
2 group was significantly higher than that of
PhoP
c group at .05 significance level. The mean cecum score of
PhoP
cAvrA
2/AvrA
+ group is lower than that of PhoP
cAvrA
2
group with trend evidence (p-value=.06). Overall, inflammation
score in the AvrA
2-infected mice was higher than the PhoP
c-o r
PhoP
c AvrA
2/AvrA
+–infected mice at 3 weeks postinfection
(Fig. 4B). These data indicate that AvrA expression consistently
suppressed intestinal inflammation.
Changes in the weights of spleen and liver
post–Salmonella infection
Both liver and spleen are involved in Salmonella infection. We
measured the weights of spleens and livers after various lengths of
infection. At week 3, significant spleen weight increase was found
in all the Salmonella infection groups. At week 27, the AvrA
2
infection group had significant heavier spleens than the control
group without Salmonella (Fig. 5A). Similarly, the infection groups
had significantly heavier livers than those in the untreated control
group at week 3. At week 6, both PhoP
c and AvrA
2 infection
significantly increased liver weight compared to the control
(Fig. 5B). Enlarged livers and spleens were found in the
Salmonella-infected groups. Fig. 5C shows the liver and spleens
from mice at 27 weeks postinfection.
Salmonella translocation in spleen, liver, and gallbladder
in vivo
Salmonella translocation is commonly reported in Salmonella-
infected patients and animals [29] [30,31]. Using our chronic
Salmonella-infected mouse model, we further observed the Salmo-
nella burden in various organs over 27 weeks. The numbers of
CFU were determined by plating on MacConkey agar plates for
Salmonella colonies. Fecal cultures showed the persistence Salmonella
in the intestine for 27 weeks. Our data also showed Salmonella
translocation in spleen, liver, and gallbladder (Fig. 6). The PhoP
c
infection group had the highest bacterial number in the
gallbladder. The overall physical features of PhoP
c-infected mice
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2, even though extensive Salmonella invasion
was identified in the intestine and other organs.
Distribution of Salmonella in gallbladder
Thegallbladderisapermissivesite forSalmonella.Salmonellainfects
the single epithelial cell layer of the gallbladder but rarely
translocates to the underlying lamina propria [32]. Therefore, we
investigated the distribution of Salmonella in the gallbladder using
immunostaining. Our data indicate the presence of Salmonella in the
gallbladder at 27 weeks postinfection (Fig 7A). Salmonella localized to
the epithelial cells, which is consistent with a recent paper on
Salmonella invasion [32]. Moreover, PhoP
c-infected mice had more
abundant Salmonella in the gallbladder than the other groups.
Liver abscess induced by chronic Salmonella infection
Liver abscess was found in mice with chronic Salmonella infection
(Fig. 7B). Interestingly, more liver abscesses were found in the
PhoP
c-infected group (80% of mice) than in the control mice (0%)
Figure 1. Persistent Salmonella infection in mice. (A) Flow chart of the experimental design. (B) Chronic Salmonella infection was measured by fecal
matter analysis. In a BBL CHROMagar plate, intestinal Salmonella species appear mauve (rose to purple) in color, due to metabolic differences in the
presence of selected chromogens. Other bacteria are either inhibited or produce blue-green or colorless colonies. Experimental groups: Control, normal
wild-type mice; PhoP
c, mice infected with Salmonella with normal AvrA expression; PhoP
cAvrA
2, mice infected with an AvrA
2 mutant derived from PhoP
c;
PhoP
cAvrA
2/AvrA
+, mice infected with PhoP
cAvrA
2 containing a complementary plasmid encoding AvrA. (C) Location of Salmonella in mouse intestine
using immunofluorescence staining. Green stainingin themouseintestineshowsthe invasion ofSalmonellain intestinal mucosaat27 weeks postinfection.
doi:10.1371/journal.pone.0010505.g001
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found in the PhoP
cAvrA
2-infected mice. At 10 weeks postinfec-
tion, 40% of liver abscesses was found in the PhoP
c and
PhoP
cAvrA
2/AvrA
+ groups, whereas only 20% of mice had a
liver abscess in the AvrA
2 group. These data raise the possibility
that AvrA expression increases Salmonella infection in the liver,
possibly by enhancing the translocation ability of the Salmonella
strains.
AvrA expression in Salmonella enhances Salmonella
invasion
The role of AvrA in bacterial invasion is unknown. We further
compared the invasion ability of Salmonella strains with or without
AvrA expression using pathogenic Salmonella 1344 with AvrA and
its derived mutant strain SB1117 AvrA
2. We found that Salmonella
1344 with AvrA had better invasion capability than SB1117
AvrA
2 in jejunum and colon 18 hours postinfection. The
Salmonella number in the intestine was significantly higher in mice
infected with strain SB1117 AvrA
2 than with strain 1344 (Fig. 7C).
These data indicate AvrA promotes intestinal Salmonella invasion in
vivo.
Profile of inflammatory cytokines in Salmonella-infected
mice
Inflammatory cytokines play a complex role in intestinal
inflammation. We then investigated the profile of cytokines in
mouse serum. The cytokines we tested included Colony-stimulat-
ing factor (CSF), interleukin (IL)-1b, IL-2, IL-4, IL-5, IL-6, IL-10,
Figure 2. Physiologic changes after Salmonella infection. (A) Changes in body weight after Salmonella infection. (B) The survival rate of mice
after Salmonella Typhimurium infection for 27 weeks. N=50 mice in each group. Mice were infected with indicated Salmonella Typhimurium strains
for 27 weeks. Mice were weighted every week. If a mouse showed indications of aspirated fluid or significant body weight loss (10% or more), and did
not die immediately, the mouse was humanely euthanized. The protocol was approved by the University of Rochester University Committee on
Animal Resources (UCAR).
doi:10.1371/journal.pone.0010505.g002
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(TNF)- a. At 1 week postinfection, significant differences in IL-12
secretion were found among PhoP
c, AvrA
2, and AvrA
2/AvrA
+.
For IFN-c, significant differences were also found at 1 and 3 weeks
postinfection. TNF-a was significantly increased in the AvrA
2
group at 1 week postinfection. At 3 weeks, both AvrA
2 and
AvrA
2/AvrA
+ had significantly higher TNF-a in serum, whereas
there was no detectable TNF-a in the PhoP
c-infected mice. We
found no differences in IL1b or IL-4. There was no detectable IL-
10 or CSF in any experimental group (Fig. 8). Overall, AvrA
expression in Salmonella suppressed the secretion of cytokines,
namely IL-12, IFN-c, and TNF-a.
Discussion
In the current study, we have established a chronic bacterial
infected mouse model with Salmonella Typhimurium colonization
in the mouse intestine for 27 weeks. Many researchers have taken
advantage of the colitis induced by Salmonella Typhimurium to
study the early phase of inflammation and infection. However,
only a few reports have been on chronic infection in vivo [1]. Our
model with the persistent presence of Salmonella AvrA
+ and AvrA
2
in the GI tract allows us to explore the long-term host–bacterial
interaction, infection, inflammation, immunology, signal trans-
duction, and tumorigenesis.
Moreover, we identified the long-term effects of a Salmonella
effector protein AvrA in vivo. We found that AvrA consistently
inhibits intestinal inflammation in vivo. This study provides
fundamental knowledge and insight into the mechanism of how
enteric bacterial protein AvrA regulates intestinal inflammation and
infection over the long term. Furthermore, our data demonstrate
that AvrA expression in Salmonella increases bacterial invasion and
translocation. Bacterial infection and inflammation are known to be
associated with tumorigenesis. Future studies will use colon cancer
models to investigate the effects of AvrA in tumorigenesis.
Liver abscess was observed in mice with chronic Salmonella
infection without intestinal symptoms. These data are consistent
with clinical case reports on the Salmonella infection in human [33].
Peritoneum adhesion to the liver (peritonitis), infection in the
uterine horn, otisis, and eye infection have also been found in
some mice, induced by bacterial translocation.These observations
have also been reported in studies of Salmonella-infected humans
and chickens [30,31] [34].
Liver abscess and Salmonella translocation in the gallbladder are
associated with a mutant Salmonella PhoP
c, which has been used as
a non-pathogenic Salmonella for intestinal inflammation studies.
These observations raise concerns about using mutated Salmonella
as a vector in cancer therapy. Further studies are needed to
confirm the safety of these approaches for tumor therapy.
One limitation of this study is that PhoP
c is not wild-type
pathogenic Salmonella. We had infected C57BL/6 mice with
pathogenic salmonella SL1344 or SL14028. However, both strains
caused death in over 90% of mice within 2 weeks of infection.
Recent studies demonstrate that an early and rapid inflammatory
response results in protection against the pathological effects of S.
Typhimurium infection in Nramp1
+/+ mice [35]. However, the
C57BL/6 mice used in the current study were Nramp1
2/2.
Nramp1
+/+ mice should be used to further understand the
inflammatory response during pathogenic Salmonella-induced
colitis in chronic inflammation.
In this study, we uncovered several novel aspects of Salmonella
and effector AvrA: (1) we established a chronic Salmonella infection
model to study inflammation, infection, and cancer; (2) we found
that the AvrA level in Salmonella may alter its capacity of invasion
and translocation; (3) we showed the biological effects of AvrA in
inhibiting intestinal inflammation in vivo; and (4) we found that
Table 1. Body weight of mice infected with Salmonella for 27 weeks.
Groups 0 week 1 week 2 weeks 3 weeks 4 weeks 5 weeks 6 weeks
Control 16.7861.05 16.9161.28 18.2661.23 19.3161.26 20.2661.15 20.5261.15 20.9261.13
PhoP
c 16.8961.03 17.1461.19 17.4361.63 18.6861.78 20.0561.11 20.3361.22 20.8461.02
PhoP
cAvrA
2 16.9161.12 16.9661.39 17.0662.14 18.7162.18 20.1561.56 20.2161.57 20.8361.39
PhoP
cAvrA
2/AvrA
+ 16.9460.96 17.1761.02 17.6361.42 18.4462.03 20.0961.17 19.9061.18 20.2761.49
7 weeks 8 weeks 9 weeks 10 weeks 11 weeks 12 weeks 13 weeks
Control 21.8061.46 21.8961.70 22.1261.40 22.1861.55 22.2461.55 23.0861.43 23.5862.11
PhoP
c 21.3061.62 21.7961.54 21.9161.53 22.1261.51 22.2162.04 22.6861.66 23.1762.26
PhoP
cAvrA
2 21.2761.61 21.7161.49 21.7461.15 22.0361.59 22.0061.60 22.5061.31 22.7561.60
PhoP
cAvrA
–/AvrA
+ 20.9061.04 21.2061.15 21.4061.07 21.8061.48 21.6060.55 21.7061.10 22.0061.41
14 weeks 15 weeks 16 weeks 17 weeks 18 weeks 19 weeks 20 weeks
Control 24.0062.00 24.3862.01 24.4161.88 24.9161.85 25.0461.36 25.1161.49 25.4461.92
PhoP
c 23.5662.12 24.0862.25 24.3862.85 24.8163.10 25.1362.39 25.2262.52 25.3662.36
PhoP
cAvrA
2 23.1361.72 23.8861.64 24.0061.31 24.2561.67 24.4161.67 24.2961.74 24.6361.60
PhoP
cAvrA
2/AvrA
+ 22.4061.34 22.6060.97 22.6060.89 23.4061.14 23.6061.47 23.7261.58 24.0061.87
21 weeks 22 weeks 23 weeks 24 weeks 25 weeks 26 weeks 27 weeks
Control 25.4161.90 25.3462.37 25.5861.58 25.8361.73 26.1362.35 26.5262.57 26.6562.87
PhoP
c 25.4762.03 25.5362.64 25.9362.43 26.1362.75 26.6062.75 26.6262.96 26.7563.58
PhoP
cAvrA
2 24.3861.85 24.5562.21 25.0061.41 25.0061.20 25.1361.46 25.4662.37 25.6862.26
PhoP
cAvrA
2/AvrA
+ 24.1861.55 24.6261.65 24.8061.48 24.9261.89 24.9661.66 25.2462.64 25.5662.43
doi:10.1371/journal.pone.0010505.t001
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PLoS ONE | www.plosone.org 5 May 2010 | Volume 5 | Issue 5 | e10505Figure 3. Intestinal shortening induced by Salmonella in vivo. (A) Length of ceca. (B) (C) Lengths of small intestine and colon. N=50 mice in
each group and 5–10 mice at each time point.
doi:10.1371/journal.pone.0010505.g003
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c induced less intestinal pathology but
more liver abscess and gallbladder translocation. Infection,
inflammation, and certain cancers are intimately linked
[36,37,38]. In addition to providing insights into salmonellosis,
an important and timely public health problem, studies using
chronically Salmonella-infected mice could improve our under-
standing of the roles of bacteria in infectious diseases, inflamma-
tory bowel diseases, and colitis-associated cancer.
Figure 4. Pathologic changes caused by the chronic Salmonella infection in streptomycin-pretreated mice. (A) H & E staining of cecum
in mice infected with S. Typhimurium at 1, 3, 6, 10 and 27 weeks postinfection compared to the wild-type mice (Control). C: Control; P: PhoP
c; A-:
PhoP
cAvrA
2; and A+: PhoP
cAvrA
2/AvrA
+. (B) Histological score of cecal inflammation. Data are from three mice in each group at each time point.
*, p,0.05.
doi:10.1371/journal.pone.0010505.g004
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PLoS ONE | www.plosone.org 7 May 2010 | Volume 5 | Issue 5 | e10505Figure 5. Liver and spleen affected by Salmonella infection in vivo. (A) Weights of spleens in mice after Salmonella infection for 27 weeks. (B)
Weights of livers in mice after Salmonella infection for 27 weeks. Data are from 5–10 mice in each group at each time point. **, p,0.01. ***, p,0.001.
(C) Enlarged livers and spleens after Salmonella infection for 27 weeks.
doi:10.1371/journal.pone.0010505.g005
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Bacterial strains and growth condition
Bacterial strains used in this study included Salmonella typhimurium
wild-type strain ATCC14028 (WT-SL) and Salmonella mutant
strains PhoP
c [39], PhoP
cAvrA
2, and PhoP
cAvrA
2/AvrA
+
(Table 3). Non-agitated microaerophilic bacterial cultures were
prepared by inoculating 10 ml of Luria-Bertani broth with 0.01 ml
of a stationary-phase culture followed by overnight incubation
(,18 h) at 37uC, as previously described [21].
Streptomycin pre-treated mouse model
Animal experiments were performed by using specific pathogen–
free female C57BL/6 mice (Taconic) that were 6–7 weeks old, as
previously described [25]. Water and food were withdrawn 4 h
before oral gavage with 7.5 mg/mouse of streptomycin (100 mlo f
sterile solution). Afterwards, animals were supplied with water and
food ad libitum. Twenty hours after streptomycin treatment, water
and food were withdrawn again for four hours before the mice were
infected with 1610
6 CFU of S. typhimurium (100-ml suspension in
HBSS) or treated with sterile HBSS (control) by oral gavage, as
previously described [40]. At 1, 3, 6, 10, and 27 weeks after
Salmonellainfection,tissuesampleswerecollected.Ifa mouseshowed
indications of aspirated fluid or significant body weight loss (10% or
more), and did not die immediately, the mouse was humanely
euthanized.Allanimalswerehandledinstrictaccordancewith good
animal practice as defined by the relevant national and/or local
animal welfare bodies, and all animal work was approved by the
University of Rochester University Committee on Animal Resourc-
es (UCAR) committee (UCAR 2007-065).
Detection of Salmonella in intestine
Mouse feces (about 100 mg) were collected, vortexed in
phosphate-buffered saline (PBS), and centrifuged for 10 min at
800 rpm. The sample was transferred to a clean microfuge tubeand
centrifuged again at 6000 rpm for 5 min. The supernatant was
discarded, 200 mL PBS was added to the pellet, and it was vortexed.
Intestinal Salmonella was detected by culturing fecal content at 37uC
overnight on a BBL CHROMagar plate (BD Biosciences, San Jose,
CA, USA). Salmonella species appeared mauve (rose to purple).
Microbial analysis
After euthanasia, 1-mlsamples fromthe cecal contents ofcolonized
mice were taken and serially diluted in PBS. Total bacterial
concentrations were determined by using counting chambers.
Salmonella distribution was also determined by immunostaining.
Salmonella burden in intestine, gallbladder, spleen, and
liver
Intestine, gallbladder, spleen, and liver were dissected from each
mouse, put into 14-ml tubes with 5 ml sterile PBS, cut into pieces
Figure 6. Numbers of Salmonella in different organs at 27 weeks postinfection in vivo. (A) Feces. (B) Spleen. (C) Gallbladder. (D) Liver. N=5
mice in each group.
doi:10.1371/journal.pone.0010505.g006
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PT2100 (Kinematica, Switzerland). Each homogenate was diluted
10006to 10,0006with LB, plated (100 ml) on MacConkey agar
plates, and incubated at 37uC overnight. Colony-forming units
were quantified.
Histological testing
Tissues were fixed in 10% neutral buffered formaldehyde for 4
to 12 h, transferred into 70% ethanol, and processed by standard
techniques. Sections (5 mm) were stained with hematoxylin and
eosin (H & E). For immunostaining, antigens were retrieved by 10-
Figure 7. Salmonella translocation and infection in gallbladder and liver. (A) Salmonella distribution in the gallbladder at 27 weeks after
Salmonella infection. Salmonella: green staining (indicated with white arrows); nucleus: blue. (B) Liver abscess found in the PhoP
c-infected mouse
(indicated with an arrow). (C) Numbers of Salmonella in intestine at 18 hours post-infection.
doi:10.1371/journal.pone.0010505.g007
Table 2. Percentage of mice with liver abscess.
6 weeks (n=5 mice) 10 weeks (n=5 mice)
Control 0 0
PhoP
c 80% 40%
PhoP
cAvrA
2 02 0 %
PhoP
cAvrA
2/AvrA
+ 04 0 %
doi:10.1371/journal.pone.0010505.t002
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PLoS ONE | www.plosone.org 10 May 2010 | Volume 5 | Issue 5 | e10505Figure 8. Inflammatory cytokines in chronically Salmonella-infected mice. The cytokines included CSF, IL-1b, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12
(p40/p70), IFN-c, and TNF-a. They were tested in mouse serum using a mouse Cytokine 10-Plex Panel. * p,0.01. ** p,0.0005. Each single experiment
was assayed in triplicate. Data are means 6 SD of n=4 mice in each group.
doi:10.1371/journal.pone.0010505.g008
Table 3. Salmonella strains used in this study.
Name Description References or source
PhoP
c Non-pathogenic complex regulator mutant derived from wild-type SL14028 Miller et al., 1990
PhoP
c AvrA2 AvrA
2 mutation derived from PhoP
c Collier-Hyams et al., 2002
PhoP
cAvrA2/AvrA+ PhoP
cAvrA
2 with complemented plasmid encoding AvrA Collier-Hyams et al., 2002
SL1344 Wild-type Salmonella 1344 strain Hardt et al., 1997 Provided by Dr. Galan
SB1117 SL 1344 with AvrA deletion Hardt et al., 1997 Provided by Dr. Galan
doi:10.1371/journal.pone.0010505.t003
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inflammatory scores were performed by a validated scoring system
[41]. Salmonella distribution in intestine was determined by
immunostaining using anti–Salmonella lipopolysaccharide antibody
(Santa Cruz Biotechnology, Santa Cruz, CA, USA).
Salmonella-induced mouse cytokine secretion
Mouse blood samples were collected by cardiac puncture and
placed in tubes containing EDTA (10 mg/ml) [20,22]. Mouse
cytokines were measured using a mouse cytokine 10-Plex Panel kit
(Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s
instructions. Briefly, beads of defined spectral properties were
conjugated to protein-specific capture antibodies and added along
with samples (including standards of known protein concentration,
control samples, and test samples) into the wells of a filter-bottom
microplate, where proteins bound to the capture antibodies over
the course of a 2-hour incubation. After washing the beads,
protein-specific biotinylated detector antibodies were added and
incubated with the beads for 1 hour. After removal of excess
biotinylated detector antibodies, the streptavidin-conjugated
fluorescent protein R-phycoerythrin (streptavidin-RPE) was added
and allowed to incubate for 30 minutes. After washing to remove
unbound streptavidin-RPE, the beads were analyzed with the
Luminex detection system (PerkinElmer CS1000 Autoplex
Analyzer).
Statistical analysis
Data are expressed as mean 6 SD. All statistical tests were 2-
sided. P values of less than .05 were considered to be statistically
significant. For cecum data, four areas of mouse body were
checked to obtain the average infection score. Then, multiple
comparisons of mean infection score were performed using
ANOVA. Following analysis of overall group differences on the
mean scores at p#.05 alpha levels were adjusted using the Tukey
correction for multiple comparisons. As the study involved a
longitudinal design, the generalized estimating equations (GEE)
was utilized to provide statistical inference. The GEE approach is
widely used due to its less stringent distributional assumptions and
robustness properties, yielding valid inference regardless of the
data distribution [42]. Thus, GEE provides more robust inference
than the other popular generalized linear mixed-effects model, as
the latter imposes analytic distributions that are often at odd with
the distributions of data. Since, the pick-up mice for each
experiment is random, we assume the loss of mice is completely
random, the missing data issue does not consider. Therefore, the
GEE procedure was used to assess treatment effects for each of the
mouse weight outcomes. The analysis was conducted using the
Genmod procedure in SAS. The overall treatment effects were
modeled using the time by treatment interaction term through
intake (week 0) to week 27. Statistical analyses were performed
using SAS version 9.2 (SAS Institute, Inc., Cary, NC).
Author Contributions
Conceived and designed the experiments: RL SW XL YX YgZ JS.
Performed the experiments: RL SW XL YgZ JS. Analyzed the data: RL
SW XL YX JS. Contributed reagents/materials/analysis tools: JS. Wrote
the paper: RL YX JS.
References
1. Grassl GA, Valdez Y, Bergstrom KS, Vallance BA, Finlay BB (2008) Chronic
enteric salmonella infection in mice leads to severe and persistent intestinal
fibrosis. Gastroenterology 134: 768–780.
2. Gradel KO, Nielsen HL, Schonheyder HC, Ejlertsen T, Kristensen B, et al.
(2009) Increased short- and long-term risk of inflammatory bowel disease after
salmonella or campylobacter gastroenteritis. Gastroenterology 137: 495–501.
3. Kumar S (2006) Infection as a risk factor for gallbladder cancer. J Surg Oncol
93: 633–639.
4. Siccardi D, Mumy KL, Wall DM, Bien JD, McCormick BA (2008) Salmonella
enterica serovar Typhimurium modulates P-glycoprotein in the intestinal
epithelium. Am J Physiol Gastrointest Liver Physiol 294: G1392–1400.
5. Mager DL (2006) Bacteria and cancer: cause, coincidence or cure? A review.
J Transl Med 4: 14.
6. Arrach N, Zhao M, Porwollik S, Hoffman RM, McClelland M (2008)
Salmonella promoters preferentially activated inside tumors. Cancer Res 68:
4827–4832.
7. Zhao M, Yang M, Li XM, Jiang P, Baranov E, et al. (2005) Tumor-targeting
bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella
typhimurium. Proc Natl Acad Sci U S A 102: 755–760.
8. Zhao M, Geller J, Ma H, Yang M, Penman S, et al. (2007) Monotherapy with a
tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic
mouse models of human prostate cancer. Proc Natl Acad Sci U S A 104:
10170–10174.
9. Hapfelmeier S, Ehrbar K, Stecher B, Barthel M, Kremer M, et al. (2004) Role of
the Salmonella pathogenicity island 1 effector proteins SipA, SopB, SopE, and
SopE2 in Salmonella enterica subspecies 1 serovar Typhimurium colitis in
streptomycin-pretreated mice. Infect Immun 72: 795–809.
10. Galan JE (2001) Salmonella interactions with host cells: type III secretion at
work. Annu Rev Cell Dev Biol 17: 53–86.
11. Galan JE (2007) SnapShot: effector proteins of type III secretion systems. Cell
130: 192.
12. Schlumberger MC, Hardt WD (2006) Salmonella type III secretion effectors:
pulling the host cell’s strings. Curr Opin Microbiol 9: 46–54.
13. Knodler LA, Celli J, Hardt WD, Vallance BA, Yip C, et al. (2002) Salmonella
effectors within a single pathogenicity island are differentially expressed and
translocated by separate type III secretion systems. Mol Microbiol 43:
1089–1103.
14. Broberg CA, Orth K Tipping the balance by manipulating post-translational
modifications. Curr Opin Microbiol 13: 34–40.
15. Ibarra JA, Steele-Mortimer O (2009) Salmonella--the ultimate insider.
Salmonella virulence factors that modulate intracellular survival. Cell Microbiol
11: 1579–1586.
16. Haraga A, Ohlson MB, Miller SI (2008) Salmonellae interplay with host cells.
Nat Rev Microbiol 6: 53–66.
17. Du F, Galan JE (2009) Selective inhibition of type III secretion activated
signaling by the Salmonella effector AvrA. PLoS Pathog 5: e1000595.
18. Collier-Hyams LS, Zeng H, Sun J, Tomlinson AD, Bao ZQ, et al. (2002)
Cutting edge: Salmonella AvrA effector inhibits the key proinflammatory, anti-
apoptotic NF-kappa B pathway. J Immunol 169: 2846–2850.
19. Hardt WD, Galan JE (1997) A secreted Salmonella protein with homology to an
avirulence determinant of plant pathogenic bacteria. Proc Natl Acad Sci U S A
94: 9887–9892.
20. Liao AP, Petrof EO, Kuppireddi S, Zhao Y, Xia Y, et al. (2008) Salmonella type
III effector AvrA stabilizes cell tight junctions to inhibit inflammation in
intestinal epithelial cells. PLoS ONE 3: e2369.
21. Sun J, Hobert ME, Rao AS, Neish AS, Madara JL (2004) Bacterial activation of
beta-catenin signaling in human epithelia. Am J Physiol Gastrointest Liver
Physiol 287: G220–227.
22. Ye Z, Petrof EO, Boone D, Claud EC, Sun J (2007) Salmonella effector AvrA
regulation of colonic epithelial cell inflammation by deubiquitination.
Am J Pathol 171: 882–892.
23. Liu X, Lu R, Wu S, Sun J Salmonella regulation of intestinal stem cells thro-
ugh the Wnt/beta-catenin pathway. FEBS Lett 584: 911–916.
24. Sun J, Hobert ME, Duan Y, Rao AS, He TC, et al. (2005) Crosstalk between
NF-kappaB and beta-catenin pathways in bacterial-colonized intestinal epithelial
cells. Am J Physiol Gastrointest Liver Physiol 289: G129–137.
25. Duan Y, Liao AP, Kuppireddi S, Ye Z, Ciancio MJ, et al. (2007) beta-Catenin activity
negatively regulates bacteria-induced inflammation. Lab Invest 87: 613–624.
26. Neish AS, Gewirtz AT, Zeng H, Young AN, Hobert ME, et al. (2000)
Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha
ubiquitination. Science 289: 1560–1563.
27. Barthel M, Hapfelmeier S, Quintanilla-Martinez L, Kremer M, Rohde M, et al.
(2003) Pretreatment of mice with streptomycin provides a Salmonella enterica
serovar Typhimurium colitis model that allows analysis of both pathogen and
host. Infect Immun 71: 2839–2858.
28. Woo H, Okamoto S, Guiney D, Gunn JS, Fierer J (2008) A model of Salmonella
colitis with features of diarrhea in SLC11A1 wild-type mice. PLoS ONE 3: e1603.
29. Vidal JE, da Silva PR, Schiavon Nogueira R, Bonasser Filho F, Hernandez AV
(2003) Liver abscess due to Salmonella enteritidis in a returned traveler with
HIV infection: case report and review of the literature. Rev Inst Med Trop Sao
Paulo 45: 115–117.
30. Okamura M, Kamijima Y, Miyamoto T, Tani H, Sasai K, et al. (2001)
Differences among six Salmonella serovars in abilities to colonize reproductive
organs and to contaminate eggs in laying hens. Avian Dis 45: 61–69.
Salmonella AvrA In Vivo
PLoS ONE | www.plosone.org 12 May 2010 | Volume 5 | Issue 5 | e1050531. Jimenez-Saenz M, Gomez-Rodriguez BJ, Carmona I, Rebollo J, Torres Y, et al.
(2001) Salmonella dublin infection: a rare cause of spontaneous bacterial
peritonitis and chronic colitis in alcoholic liver cirrhosis. Eur J Gastroenterol
Hepatol 13: 587–589.
32. Menendez A, Arena ET, Guttman JA, Thorson L, Vallance BA, et al. (2009)
Salmonella infection of gallbladder epithelial cells drives local inflammation and
injury in a model of acute typhoid fever. J Infect Dis 200: 1703–1713.
33. Jeans AR, McKendrick MW (2007) Salmonella Paratyphi A liver abscess--
secondary infection of an amoebic liver abscess? Travel Med Infect Dis 5:
144–146.
34. Gast RK, Guard-Bouldin J, Holt PS (2004) Colonization of reproductive organs
and internal contamination of eggs after experimental infection of laying hens
with Salmonella heidelberg and Salmonella enteritidis. Avian Dis 48: 863–869.
35. Valdez Y, Diehl GE, Vallance BA, Grassl GA, Guttman JA, et al. (2008)
Nramp1 expression by dendritic cells modulates inflammatory responses during
Salmonella Typhimurium infection. Cell Microbiol 10: 1646–1661.
36. Darveau R (1999) Infection, inflammation, and cancer. Nat Biotechnol 17: 19.
37. Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, et al. (2009) A human
colonic commensal promotes colon tumorigenesis via activation of T helper type
17 T cell responses. Nat Med 15: 1016–1022.
38. Rhee KJ, Wu S, Wu X, Huso DL, Karim B, et al. (2009) Induction of persistent
colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type
C57BL/6 mice. Infect Immun 77: 1708–1718.
39. Miller SI, Mekalanos JJ (1990) Constitutive expression of the phoP regulon
attenuates Salmonella virulence and survival within macrophages. J Bacteriol
172: 2485–2490.
40. McCormick BA, Colgan SP, Delp-Archer C, Miller SI, Madara JL (1993)
Salmonella typhimurium attachment to human intestinal epithelial monolayers:
transcellular signalling to subepithelial neutrophils. J Cell Biol 123: 895–907.
41. Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, et al. (1998)
Resident enteric bacteria are necessary for development of spontaneous colitis
and immune system activation in interleukin-10-deficient mice. Infect Immun
66: 5224–5231.
42. Zeger SL, Liang KY (1986) Longitudinal data analysis for discrete and
continuous outcomes. Biometrics 42: 121–130.
Salmonella AvrA In Vivo
PLoS ONE | www.plosone.org 13 May 2010 | Volume 5 | Issue 5 | e10505